Patents by Inventor Jamie Louis Barger

Jamie Louis Barger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210290721
    Abstract: An oral formulation includes a plurality of agents that promote cellular detoxification. Agents can be included that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject, wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants, and at least one gene encoding cellular detoxifiers. In addition, at least one of the plurality of agents attenuates inflammation.
    Type: Application
    Filed: March 29, 2021
    Publication date: September 23, 2021
    Applicant: NSE Products, Inc.
    Inventors: Angela Mastaloudis, Steve Wood, Jamie Louis Barger, Richard Weindruch, Tomas Alberto Prolla, Mark Bartlett, Scott B. Ferguson
  • Publication number: 20180078601
    Abstract: An oral formulation includes a plurality of agents that promote cellular detoxification. Agents can be included that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject, wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants, and at least one gene encoding cellular detoxifiers. In addition, at least one of the plurality of agents attenuates inflammation.
    Type: Application
    Filed: August 13, 2017
    Publication date: March 22, 2018
    Applicant: NSE Products, Inc.
    Inventors: Angela Mastaloudis, Steve Wood, Jamie Louis Barger, Richard Weindruch, Tomas Alberto Prolla, Mark Bartlett, Scott B. Ferguson
  • Patent number: 9795645
    Abstract: An oral formulation as described herein can comprise pomegranate extract, panax ginseng extract, and c. sinensis, where each is present in an amount effective to counteract and/or prevent effects of aging in a subject when administered to the subject. The effects of aging can include age-related changes in gene expression.
    Type: Grant
    Filed: July 7, 2015
    Date of Patent: October 24, 2017
    Assignee: NSE PRODUCTS, INC.
    Inventors: Angela Mastaloudis, Steve Wood, Richard Weindruch, Tomas Alberto Prolla, Jamie Louis Barger, Mark Bartlett, Scott B. Ferguson, Joseph Chang
  • Publication number: 20160257996
    Abstract: Markers of caloric restriction (CR) can be identified in a selected tissue by exposing an animal to CR conditions and selecting one or more genes differentially expressed in response to CR conditions in multiple subject groups. A candidate compound can be screened for likely ability to mimic the effects of CR when administered to an animal by comparing the tissue levels of expression products of the genes in animals treated with the candidate compound to those of animals subjected to CR.
    Type: Application
    Filed: August 6, 2015
    Publication date: September 8, 2016
    Applicant: NSE PRODUCTS, INC.
    Inventors: Angela Mastaloudis, Steve Wood, Tomas Alberto Prolla, Jamie Louis Barger, Richard Weindruch, Joseph Chang
  • Publication number: 20160208330
    Abstract: Markers of caloric restriction (CR) can be identified in a selected tissue by exposing an animal to CR conditions and selecting one or more genes differentially expressed in response to CR conditions in multiple subject groups. A candidate compound can be screened for likely ability to mimic the effects of CR when administered to an animal by comparing the tissue levels of expression products of the genes in animals treated with the candidate compound to those of animals subjected to CR.
    Type: Application
    Filed: January 19, 2016
    Publication date: July 21, 2016
    Applicant: NSE Products, Inc.
    Inventors: Angela Mastaloudis, Steve Wood, Tomas Alberto Prolla, Jamie Louis Barger, Richard Weindruch, Joseph Chang
  • Publication number: 20160186257
    Abstract: Markers of caloric restriction (CR) can be identified in a selected tissue by exposing an animal to CR conditions and selecting one or more genes differentially expressed in response to CR conditions in multiple subject groups. A candidate compound can be screened for likely ability to mimic the effects of CR when administered to an animal by comparing the tissue levels of expression products of the genes in animals treated with the candidate compound to those of animals subjected to CR.
    Type: Application
    Filed: August 6, 2015
    Publication date: June 30, 2016
    Applicant: NSE PRODUCTS, INC.
    Inventors: Angela Mastaloudis, Steve Wood, Tomas Alberto Prolla, Jamie Louis Barger, Richard Weindruch, Joseph Chang
  • Publication number: 20160067291
    Abstract: An oral formulation as described herein can comprise pomegranate extract, panax ginseng extract, and c. sinensis, where each is present in an amount effective to counteract and/or prevent effects of aging in a subject when administered to the subject. The effects of aging can include age-related changes in gene expression.
    Type: Application
    Filed: July 7, 2015
    Publication date: March 10, 2016
    Applicant: NSE PRODUCTS, INC.
    Inventors: Angela Mastaloudis, Steve Wood, Richard Weindruch, Tomas Alberto Prolla, Jamie Louis Barger, Mark Bartlett, Scott B. Ferguson, Joseph Chang
  • Patent number: 9072780
    Abstract: An oral formulation as described herein can comprise pomegranate extract, panax ginseng extract, and c. sinensis, where each is present in an amount effective to counteract and/or prevent effects of aging in a subject when administered to the subject. The effects of aging can include age-related changes in gene expression.
    Type: Grant
    Filed: May 24, 2011
    Date of Patent: July 7, 2015
    Assignee: NSE Products, Inc.
    Inventors: Angela Mastaloudis, Steve Wood, Richard Weindruch, Tomas Alberto Prolla, Jamie Louis Barger, Mark Bartlett, Scott B. Ferguson, Joseph Chang
  • Publication number: 20130178379
    Abstract: Markers of caloric restriction (CR) can be identified in a selected tissue by exposing an animal to CR conditions and selecting one or more genes differentially expressed in response to CR conditions in multiple subject groups. A candidate compound can be screened for likely ability to mimic the effects of CR when administered to an animal by comparing the tissue levels of expression products of the genes in animals treated with the candidate compound to those of animals subjected to CR.
    Type: Application
    Filed: June 15, 2012
    Publication date: July 11, 2013
    Applicant: NSE Products, Inc.
    Inventors: Angela Mastaloudis, Steve Wood, Tomas Alberto Prolla, Jamie Louis Barger, Richard Weindruch, Joseph Chang
  • Publication number: 20130071369
    Abstract: An oral formulation includes a plurality of agents that promote cellular detoxification. Agents can be included that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject, wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants, and at least one gene encoding cellular detoxifiers. In addition, at least one of the plurality of agents attenuates inflammation.
    Type: Application
    Filed: March 14, 2012
    Publication date: March 21, 2013
    Applicant: NSE Products, Inc.
    Inventors: Angela Mastaloudis, Steve Wood, Jamie Louis Barger, Richard Weindruch, Tomas Alberto Prolla, Mark Bartlett, Scott B. Ferguson
  • Publication number: 20120134976
    Abstract: An oral formulation as described herein can comprise pomegranate extract, panax ginseng extract, and c. sinensis, where each is present in an amount effective to counteract and/or prevent effects of aging in a subject when administered to the subject. The effects of aging can include age-related changes in gene expression.
    Type: Application
    Filed: May 24, 2011
    Publication date: May 31, 2012
    Inventors: Angela Mastaloudis, Steve Wood, Richard Weindruch, Tomas Alberto Prolla, Jamie Louis Barger, Mark Bartlett, Scott B. Ferguson, Joseph Chang
  • Publication number: 20120040855
    Abstract: The invention provides methods of developing tissue-specific biomarkers of aging, sets of robust biomarkers identified by those methods, and uses of the biomarkers to identify nutrients and other functional ingredients or agents having anti-aging properties.
    Type: Application
    Filed: March 10, 2010
    Publication date: February 16, 2012
    Inventors: Yuanlong Pan, Steven Scott Hannah, Rondo Paul Middleton, Janet Rosann Jackson, Tomas Alberto Prolla, Richard Howard Weindruch, Jamie Louis Barger, Thomas Darwin Pugh